Emerging Infectious Diseases (Mar 2004)

Coronaviridae and SARS-associated Coronavirus Strain HSR1

  • Elisa Vicenzi,
  • Filippo Canducci,
  • Debora Pinna,
  • Nicasio Mancini,
  • Silvia Carletti,
  • Adriano Lazzarin,
  • Claudio Bordignon,
  • Guido Poli,
  • Massimo Clementi

DOI
https://doi.org/10.3201/eid1003.030683
Journal volume & issue
Vol. 10, no. 3
pp. 413 – 418

Abstract

Read online

During the recent severe acute respiratory (SARS) outbreak, the etiologic agent was identified as a new coronavirus (CoV). We have isolated a SARS-associated CoV (SARS-CoV) strain by injecting Vero cells with a sputum specimen from an Italian patient affected by a severe pneumonia; the patient traveled from Vietnam to Italy in March 2003. Ultrastructural analysis of infected Vero cells showed the virions within cell vesicles and around the cell membrane. The full-length viral genome sequence was similar to those derived from the Hong-Kong Hotel M isolate. By using both real-time reverse transcription–polymerase chain reaction TaqMan assay and an infectivity plaque assay, we determined that approximately 360 viral genomes were required to generate a PFU. In addition, heparin (100 μg/mL) inhibited infection of Vero cells by 50%. Overall, the molecular and biologic characteristics of the strain HSR1 provide evidence that SARS-CoV forms a fourth genetic coronavirus group with distinct genomic and biologic features.

Keywords